Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

‘Meat testing’ press release criticised by RUMA
RUMA said the press release fails to acknowledge the strict regulation of all antibiotic use in farm animals.
Randox Health tested beef for antibiotic residue at Aintree kitchens

RUMA has strongly criticised a press release by the Grand National sponsor Randox Health for making ‘inaccurate and misleading’ statements about the use of antibiotics in farm animals.

Randox issued the press release last week, saying it tested meat for traces of antibiotics before serving it from the Aintree kitchens to around 12,000 people. The Ladymoor Farm Beef was given the ‘all-clear’ by Randox’s Food Diagnostic division after being tested using its Biochip Array Technology.

According to its website, Randox offers ‘tools for the screening of antimicrobials, growth promoting hormones and drugs of abuse in animals and produce’. The company said it wanted to raise awareness of antibiotic resistance and is ‘working closely with the industry to promote a responsible approach to antibiotic use in farm animals’.

However, RUMA, which promotes the responsible use of medicines in farm animals, said the press release fails to acknowledge the strict regulation of all antibiotic use in farm animals, and the withdrawal periods observed to avoid the presence of antibiotics in meat, milk and other products. It also confuses residue testing with the separate issue of antibiotic resistance.

RUMA secretary John Fitzgerald referred to the press release as “an ill-conceived PR stunt” and called it “irresponsible and incorrect” to imply consumers would be harmed by antibiotics from any farm produce, when residue levels have long been tightly controlled.

“Regarding the altogether different issue of antibiotic resistance, its relationship to the testing of meat for residues is bewildering,” he added. “Antibiotic resistance is complex enough already; it should be a moral duty to clarify the facts rather than cause further confusion or, worse still, seek to use it for economic gain.”

Randox was also chastised for attributing a rise in human prescriptions of ‘last resort’ drugs to farm animals, when RUMA says farm animal sales of all antibiotics, including high priority drugs, have fallen.

RUMA said it had contacted Randox for urgent clarification. 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.